Charlene Bashore
Impact in
- Structural Biology top 5%
- Cell Biology top 5%
- Endoplasmic Reticulum Stress and Disease
Papers in ⓘ
-
- Ubiquitin and proteasome pathways 5
- Histone Deacetylase Inhibitors Research 1
-
- Endoplasmic Reticulum Stress and Disease 3
- Co-authors
- Andreas Martin (3 shared papers)Mary E. Matyskiela (2 shared papers)Gabriel C. Lander (2 shared papers)Eric Estrin (1 shared paper)Eva Nogales (1 shared paper)Ken C. Dong (1 shared paper)Jared A.M. Bard (1 shared paper)Ellen A. Goodall (1 shared paper)
- Journals
- ACS Chemical Biology (2 papers)Structure (1 paper)Nature (1 paper)Cell (1 paper)Journal of Pharmaceutical and Biomedical Analysis (1 paper)
- Partner nations
- United StatesFrance
In The Last Decade
Charlene Bashore
7 papers receiving 732 citations
Hit Papers
Peers
Comparison fields: 5 of 62
- Structural Biology 29
- Cell Biology 248
- Molecular Biology 697
- Oncology 186
- Epidemiology 206
Countries citing papers authored by Charlene Bashore
This map shows the geographic impact of Charlene Bashore's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charlene Bashore with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charlene Bashore more than expected).
Fields of papers citing papers by Charlene Bashore
This network shows the impact of papers produced by Charlene Bashore. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charlene Bashore. The network helps show where Charlene Bashore may publish in the future.
Co-authors
The 25 scholars most cited alongside Charlene Bashore, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Complete subunit architecture of the proteasome regulatory particle Hit paper breakdown → | 2012 | 482 |
| 2 | 2015 | 97 | |
| 3 | 2019 | 91 | |
| 4 | 2020 | 22 | |
| 5 | 2017 | 21 | |
| 6 | 2009 | 17 | |
| 7 | 2023 | 7 |
About Charlene Bashore
Charlene Bashore is a scholar working on Molecular Biology, Cell Biology, Oncology, Epidemiology and Radiology, Nuclear Medicine and Imaging, having authored 7 papers that have together received 737 indexed citations. Recurring topics across this work include Ubiquitin and proteasome pathways (5 papers), Endoplasmic Reticulum Stress and Disease (3 papers), Monoclonal and Polyclonal Antibodies Research (2 papers), Autophagy in Disease and Therapy (2 papers), Peptidase Inhibition and Analysis (1 paper), Enzyme Structure and Function (1 paper), Histone Deacetylase Inhibitors Research (1 paper) and Cancer-related Molecular Pathways (1 paper). The work is most often cited by research in Structural Biology (29 citations), Cell Biology (248 citations), Molecular Biology (697 citations), Oncology (186 citations) and Epidemiology (206 citations). Charlene Bashore has collaborated with scholars based in United States and France. Frequent co-authors include Andreas Martin, Mary E. Matyskiela, Gabriel C. Lander, Eric Estrin, Eva Nogales, Ken C. Dong, Jared A.M. Bard, Ellen A. Goodall, Corey M. Dambacher and Nicholas J. Skelton. Their work appears in journals such as ACS Chemical Biology, Structure, Nature, Cell and Journal of Pharmaceutical and Biomedical Analysis.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.